Name: HAE Income Statement - Haemonetics Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

HAE - Haemonetics Corp.

USD | NYSE | Healthcare

HAE Income Statement - Haemonetics Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q4 FY 26	Q3 FY 26	Q2 FY 26	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q3 FY 24	Q2 FY 24	Q3 FY 23	Q2 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q3 FY 18	Q2 FY 18	Q3 FY 17	Q2 FY 17	Q3 FY 16	Q2 FY 16	Q1 FY 16	Q4 FY 15	Q3 FY 15	Q2 FY 15	Q1 FY 15	Q4 FY 14	Q3 FY 14	Q2 FY 14
Revenues
Revenues	346.4	339.0	327.3	321.4	330.6	348.5	345.5	336.2	336.3	318.2	305.3	261.5	259.8	239.9	228.5	240.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	FY2026	FY2025	FY2024	FY2023	FY2022	FY2020	FY2019	FY2018	FY2017	FY2015	FY2014	FY2013	FY2012	FY2011	FY2009
Revenues
Revenues	1,334.0	1,360.8	1,309.1	993.2	870.5	988.5	967.6	903.9	908.8	910.4	938.5	892.0	727.8	645.4	597.9
Cost of Revenue	546.4	611.9	617.5	487.7	472.6	504.0	550.0	492.0	502.9	476.0	470.1	463.9	358.6	307.9	289.7
Gross Profit	787.6	749.0	691.5	505.5	397.8	484.5	417.5	411.9	405.9	434.4	468.4	428.1	369.2	337.5	308.2
Operating Expenses
Research & Development	59.8	62.7	54.4	46.8	32.9	30.9	35.7	39.2	45.0	54.2	54.2	44.4	36.8	26.4	23.9
Operating Income
Operating Income	156.7	221.8	164.9	80.8	89.7	103.4	83.5	56.2	(43.9)	40.5	46.4	56.4	88.8	83.3
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	0.4	2.0
Tax & Net
Income Tax Expense	30.7	44.4	34.3	20.3	(6.6)	10.6	18.6	14.1	2.2	14.3	1.3	11.1	22.6	22.9	25.7
Per Share
EPS Basic	2.06	3.33	2.32	0.85	1.57	1.51	1.07	0.86	(1.09)	0.33	0.68	0.76	1.32	2.29	2.34
EPS Diluted
Supplementary Data
EBITDA	268.5	337.4	262.1	178.5	174.0	213.6	193.0	145.4	46.0	126.6	128.2	121.9	138.7	126.5	122.0
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	14.4	14.2	14.9	16.3	18.3	15.8	14.1	14.4	13.3	12.7	12.7	10.9	10.0	10.9	12.7	7.5	6.8	7.8	9.0	7.0	7.4	7.5	8.7	9.0	8.6	9.4	12.4	7.5	8.5	11.4	10.9	11.6	11.3	17.2	10.6	10.9	15.4	13.8	14.2	14.9
Selling General & Administrative	120.9	109.2	101.6	110.7	115.1	106.5	106.9	108.2	111.7	115.3	94.7	92.2	80.7	75.8	91.2	65.6
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	27.3	27.4	28.3	28.8	28.2	29.0	29.2	29.1	14.2	13.6	13.1	22.4	-	-	25.0	-
Amortization of Intangibles	12.0	12.4	12.8	13.3	13.0	13.9	14.2	14.5	9.3	9.4	10.4	8.4	12.2	11.4	12.4	7.8
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	221.2	135.0	136.3	138.4	121.7	134.5	135.7	135.2	131.9	135.2	115.4	111.5	102.9	98.0	106.7	79.8

Operating Income
Operating Income	(23.0)	67.4	58.5	53.9	71.3	59.0	51.7	39.8	46.0	35.3	43.3	30.8	35.7	24.5	1.4	40.4	58.8	11.7	26.0	40.9	49.7	(13.3)	23.9	28.3	26.1	5.3	1.0	24.3	21.2	(7.9)	(61.2)	19.2	3.6	11.5	18.3	12.4	(1.7)	11.8	17.9	23.4

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(5.4)	(7.4)	(7.2)	(8.7)	(0.6)	(9.1)	(7.0)	7.0	(1.9)	(2.5)	(1.1)	(5.3)	(4.3)	(4.6)	(4.4)	(3.1)	(3.8)
Pre-Tax Income	(28.4)	60.0	51.3	45.2	70.7	49.9	44.7	46.7	44.0	32.8	42.2	25.5	31.4	19.9	(3.0)	37.4	55.0

Tax & Net
Income Tax Expense	(8.3)	15.2	12.6	11.1	12.8	12.4	10.9	8.3	12.8	7.9	9.3	5.6	8.2	5.1	1.4	5.5	6.9	(2.5)	4.3	7.9	7.6	(9.2)	1.0	7.2	4.3	6.1	6.8	2.8	3.5	0.3	(3.9)	3.7	1.9	12.6	(0.0)	2.3	(0.6)	(0.4)	(1.3)	4.3
Net Income From Continuing Ops	(20.1)	44.7	38.7	34.0	58.0	37.5	33.8	38.4	31.2	24.9	32.9	19.9	23.2	14.9	(4.5)	31.9	48.1
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(20.1)	44.7	38.7	34.0	58.0	37.5	33.8	38.4	31.2	24.9	32.9	19.9	23.2	14.9	(4.5)	31.9	48.1
Net Income Attributable To Parent	(20.1)	44.7	38.7	34.0	58.0	37.5	33.8	38.4	31.2	24.9	32.9	19.9	23.2	14.9	(4.5)	31.9
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(20.1)	44.7	38.7	34.0	58.0	37.5	33.8	38.4	31.2	24.9	32.9	19.9	23.2	14.9	(4.5)

Per Share
EPS Basic	-	0.96	0.81	0.71	-	0.75	0.66	0.75	0.62	0.49	0.65	0.39	0.45	0.29	(0.09)	0.63	0.95	0.21	-	0.59	0.74	(0.17)	-	0.36	0.36	(0.05)	(0.12)	0.38	0.30	(0.20)	(1.17)	0.25	(0.01)	-	0.31	0.15	(0.07)	-	0.31	0.32
EPS Diluted	-	0.95	0.81	0.70	-	0.74	0.66	0.74	0.61	0.48	0.64	0.38	0.45	0.29	(0.09)	0.62	0.94	0.21
Shares Basic	-	46.8	47.6	48.1	-	50.3	50.9	50.9	50.8	50.7	50.5	51.2	51.1	51.0	50.9	50.8	50.7	50.4
Shares Diluted	-	47.0	47.7	48.4	-	50.6	51.2	51.6	51.4	51.4	51.2	51.7	51.3	51.5	50.9	51.4	51.1	51.2

Supplementary Data
EBITDA	4.3	94.8	86.7	82.6	99.5	88.1	80.9	68.9	60.2	48.9	56.4	53.2	-	-	26.4	-	-	32.4	-	-	-	14.1	-	-	-	31.7	-	-	-	14.7	-	-	25.9	-	-	-	18.8	-	-	-
EBIT	(23.0)	67.4	58.5	53.9	71.3	59.0	51.7	39.8	46.0	35.3	43.3	30.8	35.7	24.5	1.4	40.4	58.8	11.7	26.0